Metabolomics Workbench : NIH Data Repository

Clustering data with hclust algorithm for (Study ST004548)

(Analysis AN007639)

Metabolite	Structure	F1	F2	F3	F4	F5	F6	F7	F8	F9	F10	F11	F12	F13	F14	F15	F16	F17	F18	F19	F20	F21	F22	F23	F24	F25	F26	F27	F28	F29	F30
Cit	ME1288193	0.35	0.36	0.33	0.35	0.37	0.31	0.31	0.29	0.28	0.37	1.29	1.34	1.32	1.41	1.41	1.15	1.19	0.98	1.15	1.08	1.02	0.94	0.94	0.94	1.02	0.67	0.72	0.68	0.71	0.70
Spermidine	ME1288207	0.48	0.51	0.47	0.47	0.49	0.31	0.30	0.29	0.26	0.36	0.60	0.53	0.55	0.57	0.60	0.59	0.58	0.44	0.52	0.51	0.38	0.39	0.38	0.41	0.41	0.31	0.31	0.32	0.29	0.28
Orn	ME1288202	0.33	0.33	0.31	0.31	0.33	0.23	0.25	0.23	0.22	0.39	0.50	0.41	0.40	0.43	0.49	0.46	0.41	0.33	0.39	0.38	0.29	0.29	0.29	0.32	0.34	0.25	0.26	0.26	0.25	0.27
Lys	ME1288200	0.41	0.42	0.37	0.38	0.41	0.29	0.32	0.28	0.28	0.46	0.42	0.37	0.37	0.37	0.42	0.40	0.35	0.27	0.32	0.31	0.29	0.29	0.29	0.33	0.33	0.25	0.24	0.26	0.24	0.27
Spermine	ME1288208	0.39	0.44	0.40	0.40	0.44	0.33	0.33	0.35	0.28	0.36	0.49	0.34	0.41	0.36	0.39	0.36	0.37	0.30	0.35	0.31	0.30	0.28	0.29	0.32	0.30	0.29	0.29	0.31	0.29	0.27
Gly	ME1288196	0.69	0.71	0.66	0.69	0.69	0.70	0.76	0.72	0.73	0.88	0.57	0.55	0.57	0.54	0.59	0.55	0.55	0.48	0.54	0.54	0.61	0.60	0.58	0.64	0.60	0.62	0.61	0.63	0.65	0.64
His	ME1288197	0.76	0.79	0.77	0.75	0.82	0.75	0.74	0.72	0.65	0.91	0.68	0.65	0.67	0.66	0.72	0.63	0.67	0.53	0.62	0.57	0.68	0.63	0.64	0.68	0.65	0.58	0.61	0.63	0.61	0.61
Thr	ME1288209	0.73	0.75	0.67	0.68	0.73	0.64	0.67	0.60	0.61	0.77	0.66	0.63	0.68	0.65	0.68	0.66	0.62	0.53	0.60	0.61	0.60	0.59	0.61	0.60	0.59	0.57	0.56	0.58	0.57	0.60
Asp	ME1288192	0.62	0.66	0.63	0.63	0.64	0.57	0.57	0.54	0.52	0.69	0.41	0.41	0.41	0.41	0.44	0.39	0.39	0.32	0.36	0.35	0.59	0.56	0.56	0.57	0.54	0.47	0.48	0.51	0.49	0.48
Glu	ME1288195	0.50	0.53	0.49	0.49	0.53	0.51	0.51	0.47	0.44	0.60	0.48	0.47	0.50	0.48	0.51	0.49	0.48	0.41	0.46	0.46	0.48	0.47	0.46	0.47	0.46	0.44	0.44	0.44	0.44	0.46
Ser	ME1288205	0.58	0.60	0.57	0.58	0.63	0.53	0.54	0.51	0.50	0.64	0.60	0.56	0.57	0.57	0.59	0.56	0.54	0.46	0.53	0.52	0.51	0.49	0.52	0.53	0.51	0.46	0.46	0.48	0.47	0.48
Ala	ME1288189	0.63	0.66	0.63	0.63	0.67	0.59	0.62	0.58	0.55	0.71	0.59	0.58	0.58	0.59	0.63	0.58	0.55	0.47	0.53	0.52	0.56	0.54	0.54	0.57	0.57	0.51	0.51	0.53	0.52	0.52
GABA	ME1288194	0.59	0.61	0.55	0.59	0.60	0.55	0.58	0.55	0.52	0.66	0.55	0.57	0.55	0.56	0.56	0.58	0.56	0.46	0.54	0.54	0.55	0.55	0.50	0.56	0.57	0.52	0.54	0.51	0.53	0.53
Trp	ME1288210	0.97	2.10	0.97	0.95	1.02	0.86	0.88	0.84	0.78	0.92	0.87	0.87	0.91	0.89	0.97	0.85	0.87	0.71	0.83	0.83	0.84	0.86	0.79	0.88	0.87	0.77	0.78	0.78	0.75	0.76
Arg	ME1288190	0.77	1.03	1.19	0.77	1.03	0.65	0.87	0.99	0.66	1.13	0.92	0.82	0.66	0.66	1.06	0.65	0.90	0.56	0.68	0.63	0.55	0.62	0.70	0.56	0.69	0.51	0.68	0.73	0.61	0.64
Val	ME1288213	0.84	0.86	0.81	0.84	0.86	0.74	0.80	0.78	0.72	0.87	0.73	0.74	0.78	0.75	0.77	0.72	0.72	0.61	0.67	0.69	0.73	0.72	0.71	0.74	0.76	0.70	0.69	0.68	0.68	0.72
Met	ME1288201	0.90	0.93	0.95	0.93	0.91	0.85	0.86	0.81	0.79	0.91	0.92	0.89	0.91	0.88	0.91	0.87	0.87	0.74	0.83	0.83	0.77	0.81	0.82	0.81	0.84	0.74	0.75	0.77	0.72	0.74
Tyr	ME1288211	0.90	0.92	0.85	0.85	0.90	0.77	0.81	0.79	0.74	0.87	0.83	0.82	0.89	0.84	0.84	0.82	0.79	0.70	0.76	0.75	0.77	0.77	0.75	0.78	0.78	0.72	0.73	0.73	0.69	0.73
Pro	ME1288204	0.92	1.15	1.29	0.95	1.14	1.00	1.28	1.41	1.02	1.29	1.03	0.94	0.85	0.79	1.22	0.76	1.05	0.74	0.84	0.85	0.82	0.90	0.96	0.82	0.96	0.83	1.06	1.08	0.96	0.97
Phe	ME1288203	0.87	1.21	1.27	0.87	1.27	0.83	1.02	1.27	0.84	1.12	1.23	1.07	0.87	0.88	1.35	0.78	1.22	0.76	0.86	0.83	0.77	0.85	0.96	0.78	0.96	0.71	0.97	0.99	0.87	0.72
Leu	ME1288199	0.83	1.15	1.33	0.83	1.16	0.78	0.96	1.23	0.79	1.08	1.13	1.02	0.84	0.81	1.36	0.74	1.06	0.69	0.82	0.80	0.69	0.83	0.91	0.74	0.94	0.67	0.92	0.96	0.81	0.70
Asn	ME1288191	0.82	1.13	1.32	0.83	1.14	0.78	0.98	1.24	0.80	1.06	1.11	1.02	0.84	0.79	1.32	0.74	1.09	0.70	0.82	0.79	0.71	0.85	0.90	0.75	0.94	0.69	0.91	0.97	0.79	0.70
Ile	ME1288198	0.82	1.13	1.33	0.83	1.13	0.79	1.00	1.23	0.81	1.07	1.10	0.99	0.83	0.78	1.31	0.73	1.05	0.69	0.82	0.77	0.70	0.85	0.91	0.77	0.95	0.69	0.93	0.95	0.82	0.70
Serotonine	ME1288206	1.11	1.19	1.09	1.18	1.16	1.15	1.24	1.21	1.19	1.26	0.85	0.89	0.87	0.89	0.91	0.81	0.77	0.77	0.77	0.74	1.00	0.99	1.08	1.05	0.98	0.88	1.01	1.04	1.06	0.96
Tyramine	ME1288212	1.03	1.03	0.99	1.04	1.02	1.00	0.99	0.97	0.94	0.98	0.99	0.94	1.01	0.96	1.01	0.98	0.99	0.86	0.96	0.95	0.94	0.97	0.94	0.97	0.96	0.93	0.92	0.96	0.89	0.90

Factors:

F1	Sample source:BT \| Treatment:300µM DCA treated \| Replicate:1
F2	Sample source:BT \| Treatment:300µM DCA treated \| Replicate:2
F3	Sample source:BT \| Treatment:300µM DCA treated \| Replicate:3
F4	Sample source:BT \| Treatment:300µM DCA treated \| Replicate:4
F5	Sample source:BT \| Treatment:300µM DCA treated \| Replicate:5
F6	Sample source:BT \| Treatment:Control \| Replicate:1
F7	Sample source:BT \| Treatment:Control \| Replicate:2
F8	Sample source:BT \| Treatment:Control \| Replicate:3
F9	Sample source:BT \| Treatment:Control \| Replicate:4
F10	Sample source:BT \| Treatment:Control \| Replicate:5
F11	Sample source:CA \| Treatment:300µM DCA treated \| Replicate:1
F12	Sample source:CA \| Treatment:300µM DCA treated \| Replicate:2
F13	Sample source:CA \| Treatment:300µM DCA treated \| Replicate:3
F14	Sample source:CA \| Treatment:300µM DCA treated \| Replicate:4
F15	Sample source:CA \| Treatment:300µM DCA treated \| Replicate:5
F16	Sample source:CA \| Treatment:Control \| Replicate:1
F17	Sample source:CA \| Treatment:Control \| Replicate:2
F18	Sample source:CA \| Treatment:Control \| Replicate:3
F19	Sample source:CA \| Treatment:Control \| Replicate:4
F20	Sample source:CA \| Treatment:Control \| Replicate:5
F21	Sample source:Co \| Treatment:300µM DCA treated \| Replicate:1
F22	Sample source:Co \| Treatment:300µM DCA treated \| Replicate:2
F23	Sample source:Co \| Treatment:300µM DCA treated \| Replicate:3
F24	Sample source:Co \| Treatment:300µM DCA treated \| Replicate:4
F25	Sample source:Co \| Treatment:300µM DCA treated \| Replicate:5
F26	Sample source:Co \| Treatment:Control \| Replicate:1
F27	Sample source:Co \| Treatment:Control \| Replicate:2
F28	Sample source:Co \| Treatment:Control \| Replicate:3
F29	Sample source:Co \| Treatment:Control \| Replicate:4
F30	Sample source:Co \| Treatment:Control \| Replicate:5

Data matrix